Literature DB >> 11272167

beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.

G Leibowitz1, M Yuli, M Y Donath, R Nesher, D Melloul, E Cerasi, D J Gross, N Kaiser.   

Abstract

Deficient insulin secretion and relative hyperproinsulinemia are characteristic features of type 2 diabetes. The gerbil Psammomys obesus appears to be an ideal natural model of the human disease because it shows increased tendency to develop diet-induced diabetes, which is associated with moderate obesity. The disease is characterized by initial hyperinsulinemia, progressing to hypoinsulinemia associated with depleted pancreatic insulin stores and an increased proportion of insulin precursor molecules in the blood and islets. Although the proinsulin translational efficacy was found to be increased in hyperglycemic animals, insulin mRNA levels were not augmented and exhibited a gradual decrease with disease progression. The development of hyperglycemia was associated with a transient increase in beta-cell proliferative activity, as opposed to a prolonged increase in the rate of beta-cell death, culminating in disruption of islet architecture. The hypothesis that glucotoxicity is responsible in part for these in vivo changes was investigated in vitro in primary islet cultures. Islets from diabetes-prone P. obesus cultured at high glucose concentrations displayed changes in beta-cell function that mimic those observed in diabetic animals. These changes include deficient insulin secretion, depleted insulin content, an increased proportion of insulin precursor molecules, a progressive increase of DNA fragmentation, and a transient proliferative response. Furthermore, insulin mRNA was not increased by short-term exposure of P. obesus islets to elevated glucose in vitro. It is proposed that beta-cell glucotoxicity in P. obesus results from the inability of proinsulin biosynthesis to keep pace with chronic insulin hypersecretion. The resulting depletion of the insulin stores may be related to deficient glucose-regulated insulin gene transcription, possibly due to defective PDX-1 (pancreatic duodenal homeobox factor-1) expression in the adult P. obesus. An additional glucotoxic effect involves the loss of beta-cell mass in hyperglycemic P. obesus as a result of progressive beta-cell death without an adequate increase in the rate of beta-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272167     DOI: 10.2337/diabetes.50.2007.s113

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  The mammal-specific Pdx1 Area II enhancer has multiple essential functions in early endocrine cell specification and postnatal β-cell maturation.

Authors:  Yu-Ping Yang; Mark A Magnuson; Roland Stein; Christopher V E Wright
Journal:  Development       Date:  2016-12-19       Impact factor: 6.868

2.  Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells.

Authors:  Fang Zhao; Fengjie Huang; Mengxiong Tang; Xiaoming Li; Nina Zhang; Akis Amfilochiadis; Yiming Li; Renming Hu; Tianru Jin; Chun Peng; Qinghua Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-01       Impact factor: 4.310

3.  Increased islet apoptosis in Pdx1+/- mice.

Authors:  James D Johnson; Noreen T Ahmed; Dan S Luciani; Zhiqiang Han; Hung Tran; Jun Fujita; Stanley Misler; Helena Edlund; Kenneth S Polonsky
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

4.  Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.

Authors:  Aurora Merovci; Devjit Tripathy; Xi Chen; Ivan Valdez; Muhammad Abdul-Ghani; Carolina Solis-Herrera; Amalia Gastaldelli; Ralph A DeFronzo
Journal:  Diabetes       Date:  2020-10-08       Impact factor: 9.461

5.  The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes.

Authors:  Chamutal Gur; Jonatan Enk; Efraim Weitman; Etty Bachar; Yaron Suissa; Guy Cohen; Rachel Ben-Haroush Schyr; Helena Sabanay; Elad Horwitz; Benjamin Glaser; Yuval Dor; Ariel Pribluda; Jacob H Hanna; Gill Leibowitz; Ofer Mandelboim
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

6.  Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure.

Authors:  O Kluth; F Mirhashemi; S Scherneck; D Kaiser; R Kluge; S Neschen; H-G Joost; A Schürmann
Journal:  Diabetologia       Date:  2010-11-24       Impact factor: 10.122

7.  Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects.

Authors:  Avital Swisa; Zvi Granot; Natalia Tamarina; Sophie Sayers; Nabeel Bardeesy; Louis Philipson; David J Hodson; Jakob D Wikstrom; Guy A Rutter; Gil Leibowitz; Benjamin Glaser; Yuval Dor
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

8.  Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus.

Authors:  Djamila Aroune; Farid Libdiri; Sophie Leboucher; Boubekeur Maouche; Sergio Marco; Salima El-Aoufi
Journal:  Saudi J Biol Sci       Date:  2016-05-18       Impact factor: 4.219

9.  PPARγ activation attenuates glycated-serum induced pancreatic beta-cell dysfunction through enhancing Pdx1 and Mafa protein stability.

Authors:  Yunxia Zhu; Ai Ma; Hongxiu Zhang; Chaojun Li
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells.

Authors:  Jianhui Liu; Lixia Guo; Fei Yin; Yonglan Zhang; Zixuan Liu; Yanwen Wang
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.